Healthcare: Air Liquide continues its development with an acquisition in the French overseas departments and territories

Increasing life expectancy and the rise in chronic diseases are major public health issues. Air Liquide is continuing to develop its home healthcare activity in France with the acquisition of SEPRODOM, a key player in home healthcare and monitoring of patients with chronic diseases in the French overseas departments and territories.

Created in 2003, SEPRODOM has nearly 90 employees, caring for 4,500 patients at home in Reunion, Mayotte, Guadeloupe, and New Caledonia.

SEPRODOM is recognised for the quality of its care for patients that need respiratory assistance at home, in particular oxygen therapy, mechanical ventilation and the treatment of sleep apnea. SEPRODOM also cares for patients that require treatment by infusion therapy and enteral nutrition at home. And finally, it also supplies and distributes medical equipment directly to patients' homes.

Air Liquide is favouring continuity for the company's management with Jean-Philippe Rouquié, backed by the expertise and commitment of his teams.

Pascal Vinet, Vice President, Healthcare Global Operations and member of the Air Liquide group's Executive Committee, commented: "This acquisition completes our service offering in French overseas departments and territories. With the integration of highly trained teams dedicated to patient care, our home healthcare service offering in France will be reinforced."